FDA Accepts Bristol Myers (BMY) sBLAs for Opdivo Combo for ESCC

Categories
About this Disease

https://www.nasdaq.com/articles/fda-accepts-bristol-myers-bmy-sblas-for-opdivo-combo-for-escc-2021-09-28